| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |